PATENT CLAIM ANALYSIS

Application Number: 16241287
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["424", "490000"]

Abstract:
An aqueous liquid suspension containing a coated drug-ion exchange resin complex comprising a core composed of an amphetamine complexed with a pharmaceutically acceptable ion-exchange resin and an uncoated amphetamine-ion exchange resin complex is provided. The coated amphetamine-ion exchange resin complex is in admixture with a polymer to form a matrix. Methods of making the coated complex and the liquid suspension are described.

Claim (Index 15):
The composition according to  claim 1 , wherein the pharmaceutically acceptable drug in the drug-ion exchange resin complex-matrix is selected from the group consisting of morphine, oxycodone, albuterol, methylphenidate, dexmethylphenidate, dextromethorphan, codeine, tramadol, pseudoephedrine, phenylephrine, hydrocodone, venlafaxine, ibuprofen, oxybutynin, clonidine, dexchlorpheniramine, fexofenadine, diphenhydramine, carbemazepine, oxymorphone, carbinoxamine, dicyclomine, chlorpheniramine, amphetamine, naproxene, diclofenac, paroxetine, and amoxicillin.

Metadata:
- Claim Count in Document: 68.0
- Percentile: 99.0
- Lexical Diversity: 1.625
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14044105', '12722857', '15200786', '13746654', '14508613']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7639588421408465
- 35 USC 102 Novelty (BERT): 0.5515661993011457
- Combined Prediction Score: 0.7427195778568765
- Mean Citation Score: 402.077908
- Max Citation Score: 402.8588
- Similarity Product: 373.34956271467206

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test